Genetic Testing Becoming More Widespread in Ovarian Cancer, But Challenges Remain
May 15, 2018
Testing for genetic alterations has become an important step in the treatment of patients with ovarian cancer. Although much has been achieved, says Mike Janicek, MD, there needs to be more widespread use of genetic testing in order to push the field forward.
Current guidelines state that any patient diagnosed with ovarian, fallopian tube, or peritoneal cancer should be offered genetic testing. Still, fewer than 20% of patients with breast and ovarian cancer who are eligible for genetic testing undergo it, Janicek says.